Crossmark

<scp>ROCK</scp> 1 is a potential combinatorial drug target for <scp>BRAF</scp> mutant melanoma

Crossref DOI link: https://doi.org/10.15252/msb.20145450

Published Online: 2014-12-23

Published Print: 2014-12

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Smit, Marjon A

Maddalo, Gianluca

Greig, Kylie

Raaijmakers, Linsey M

Possik, Patricia A

van Breukelen, Bas

Cappadona, Salvatore

Heck, Albert JR

Altelaar, AF Maarten

Peeper, Daniel S
License Information

Version of Record valid from 2014-12-23
More Information

Publication History

Received: 2014-05-26

Accepted: 2014-12-04

Published: 2014-12-23